CervoMed Inc. (CRVO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $25.26M
Last updated: Nov 17, 2026 at 4:42 PM ET
CervoMed Inc. (CRVO) Stock Chart
CervoMed (CRVO) has a latest price of $1.50 on Nov 17, 2026, 85.0% below its 52-week high of $10.00. Its price fell 80.5% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 54.8%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $4,520.01 in Oct 2016 and its lowest $1.60 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CRVO with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CRVO.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 44.6%, and over 6 months it fell 48.1%. The month-end price fell 81.5% over the 3 years through Oct 2026, a compound annual decline of 43.0%.
| Period | Change |
|---|---|
| 1 month | -35.1% |
| 3 months | -44.6% |
| 6 months | -48.1% |
| 12 months | -80.5% |
| 12 months, with dividends | -80.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -81.5% | -43.0% |
| 5 years | -95.3% | -45.7% |
| 10 years | -100.0% | -54.8% |
Price by Year
Its best calendar year was 2025, when the price rose 237.6%, and its weakest was 2018, when it fell 88.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.60 | -79.7% |
| 2025 | $7.90 | +237.6% |
| 2024 | $2.34 | -69.3% |
| 2023 | $7.63 | +0.6% |
| 2022 | $7.59 | -66.8% |
| 2021 | $22.87 | -61.6% |
| 2020 | $59.62 | +72.8% |
| 2019 | $34.50 | -76.9% |
| 2018 | $149.24 | -88.8% |
| 2017 | $1,326.77 | -47.8% |
Trading Range
The price is 34.9% below its 50-day average of $2.30 and 53.7% below its 200-day average of $3.24.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.50 | |
| 52-week high | $10.00 | -85.0% |
| 52-week low | $1.27 | +18.1% |
| 50-day average | $2.30 | -34.9% |
| 200-day average | $3.24 | -53.7% |
Price Risk
Over 3 years, its largest fall from a peak was 94.7%.
| Measure | Value |
|---|---|
| 1-year beta | 2.20 |
| Largest fall, 1 year | -86.2% |
| Largest fall, 3 years | -94.7% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CRVO
What is CRVO's 1-year price change?
CervoMed's price fell 80.5% over the past 12 months. With dividends included, the 12-month total return was -80.5%.
What is CRVO's 5-year price change?
CervoMed's month-end price fell 95.3% over the 5 years through Oct 2026, a compound annual decline of 45.7%. These figures leave out dividends.
What is CRVO's 52-week high and low?
CervoMed's 52-week high is $10.00 and its 52-week low is $1.27. Its latest price of $1.50 on Nov 17, 2026 is 85.0% below the high.
What is CRVO's beta?
CervoMed's 1-year beta against the S&P 500 is 2.20, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 86.2%.
Is the CRVO chart free?
Yes. Advanced Charting for CRVO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CRVO pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors